Selected research
Industry Research
Cas12 Nuclease Industry Research Report 2026
Market perspective
The global Cas12 Nuclease market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cas12 Nuclease is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cas12 Nuclease is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cas12 Nuclease is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cas12 Nuclease include Yeasen Biotechnology, Beyotime Biotech, Synthego, Signalchem, Sigma-Aldrich, New England Biolabs, Molecular Cloning Laboratories, Integrated DNA Technologies and Intact Genomics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cas12 Nuclease market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cas12 Nuclease Market by Company
Yeasen Biotechnology
Beyotime Biotech
Synthego
Signalchem
Sigma-Aldrich
New England Biolabs
Molecular Cloning Laboratories
Integrated DNA Technologies
Intact Genomics
GenScript
Danaher
BPS Bioscience
Cas12 Nuclease Segment by Type
Cas12a
Cas12b
Other
Cas12 Nuclease Segment by Application
Biopharmaceutical
Academic & Research Institutes
Hospitals & Diagnostic Centers
Other
Cas12 Nuclease Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cas12 Nuclease market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cas12 Nuclease and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cas12 Nuclease.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cas12 Nuclease manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cas12 Nuclease by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cas12 Nuclease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cas12a
- Cas12b
- Other
Applications
- Biopharmaceutical
- Academic & Research Institutes
- Hospitals & Diagnostic Centers
- Other
Companies covered
- Yeasen Biotechnology
- Beyotime Biotech
- Synthego
- Signalchem
- Sigma-Aldrich
- New England Biolabs
- Molecular Cloning Laboratories
- Integrated DNA Technologies
- Intact Genomics
- GenScript
- Danaher
- BPS Bioscience
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cas12 Nuclease Market Size (2021-2032)
- 2.2.2 Global Cas12 Nuclease Sales (2021-2032)
- 2.2.3 Global Cas12 Nuclease Market Average Price (2021-2032)
- 2.3 Cas12 Nuclease by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Cas12a
- 2.3.3 Cas12b
- 2.3.4 Other
- 2.4 Cas12 Nuclease by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Biopharmaceutical
- 2.4.3 Academic & Research Institutes
- 2.4.4 Hospitals & Diagnostic Centers
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cas12 Nuclease Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cas12 Nuclease Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Cas12 Nuclease Revenue of Manufacturers (2021-2026)
- 3.4 Global Cas12 Nuclease Average Price by Manufacturers (2021-2026)
- 3.5 Global Cas12 Nuclease Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cas12 Nuclease, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cas12 Nuclease, Product Type & Application
- 3.8 Global Manufacturers of Cas12 Nuclease, Established Date
- 3.9 Global Cas12 Nuclease Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Yeasen Biotechnology
- 4.1.1 Yeasen Biotechnology Company Information
- 4.1.2 Yeasen Biotechnology Business Overview
- 4.1.3 Yeasen Biotechnology Cas12 Nuclease Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Yeasen Biotechnology Cas12 Nuclease Product Portfolio
- 4.1.5 Yeasen Biotechnology Recent Developments
- 4.2 Beyotime Biotech
- 4.2.1 Beyotime Biotech Company Information
- 4.2.2 Beyotime Biotech Business Overview
- 4.2.3 Beyotime Biotech Cas12 Nuclease Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Beyotime Biotech Cas12 Nuclease Product Portfolio
- 4.2.5 Beyotime Biotech Recent Developments
- 4.3 Synthego
- 4.3.1 Synthego Company Information
- 4.3.2 Synthego Business Overview
- 4.3.3 Synthego Cas12 Nuclease Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Synthego Cas12 Nuclease Product Portfolio
- 4.3.5 Synthego Recent Developments
- 4.4 Signalchem
- 4.4.1 Signalchem Company Information
- 4.4.2 Signalchem Business Overview
- 4.4.3 Signalchem Cas12 Nuclease Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Signalchem Cas12 Nuclease Product Portfolio
- 4.4.5 Signalchem Recent Developments
- 4.5 Sigma-Aldrich
- 4.5.1 Sigma-Aldrich Company Information
- 4.5.2 Sigma-Aldrich Business Overview
- 4.5.3 Sigma-Aldrich Cas12 Nuclease Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sigma-Aldrich Cas12 Nuclease Product Portfolio
- 4.5.5 Sigma-Aldrich Recent Developments
- 4.6 New England Biolabs
- 4.6.1 New England Biolabs Company Information
- 4.6.2 New England Biolabs Business Overview
- 4.6.3 New England Biolabs Cas12 Nuclease Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 New England Biolabs Cas12 Nuclease Product Portfolio
- 4.6.5 New England Biolabs Recent Developments
- 4.7 Molecular Cloning Laboratories
- 4.7.1 Molecular Cloning Laboratories Company Information
- 4.7.2 Molecular Cloning Laboratories Business Overview
- 4.7.3 Molecular Cloning Laboratories Cas12 Nuclease Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Molecular Cloning Laboratories Cas12 Nuclease Product Portfolio
- 4.7.5 Molecular Cloning Laboratories Recent Developments
- 4.8 Integrated DNA Technologies
- 4.8.1 Integrated DNA Technologies Company Information
- 4.8.2 Integrated DNA Technologies Business Overview
- 4.8.3 Integrated DNA Technologies Cas12 Nuclease Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Integrated DNA Technologies Cas12 Nuclease Product Portfolio
- 4.8.5 Integrated DNA Technologies Recent Developments
- 4.9 Intact Genomics
- 4.9.1 Intact Genomics Company Information
- 4.9.2 Intact Genomics Business Overview
- 4.9.3 Intact Genomics Cas12 Nuclease Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Intact Genomics Cas12 Nuclease Product Portfolio
- 4.9.5 Intact Genomics Recent Developments
- 4.10 GenScript
- 4.10.1 GenScript Company Information
- 4.10.2 GenScript Business Overview
- 4.10.3 GenScript Cas12 Nuclease Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 GenScript Cas12 Nuclease Product Portfolio
- 4.10.5 GenScript Recent Developments
- 4.11 Danaher
- 4.11.1 Danaher Company Information
- 4.11.2 Danaher Business Overview
- 4.11.3 Danaher Cas12 Nuclease Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Danaher Cas12 Nuclease Product Portfolio
- 4.11.5 Danaher Recent Developments
- 4.12 BPS Bioscience
- 4.12.1 BPS Bioscience Company Information
- 4.12.2 BPS Bioscience Business Overview
- 4.12.3 BPS Bioscience Cas12 Nuclease Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 BPS Bioscience Cas12 Nuclease Product Portfolio
- 4.12.5 BPS Bioscience Recent Developments
5 Global Cas12 Nuclease Market Scenario by Region
- 5.1 Global Cas12 Nuclease Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cas12 Nuclease Sales by Region: 2021-2032
- 5.2.1 Global Cas12 Nuclease Sales by Region: 2021-2026
- 5.2.2 Global Cas12 Nuclease Sales by Region: 2027-2032
- 5.3 Global Cas12 Nuclease Revenue by Region: 2021-2032
- 5.3.1 Global Cas12 Nuclease Revenue by Region: 2021-2026
- 5.3.2 Global Cas12 Nuclease Revenue by Region: 2027-2032
- 5.4 North America Cas12 Nuclease Market Facts & Figures by Country
- 5.4.1 North America Cas12 Nuclease Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cas12 Nuclease Sales by Country (2021-2032)
- 5.4.3 North America Cas12 Nuclease Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Cas12 Nuclease Market Facts & Figures by Country
- 5.5.1 Europe Cas12 Nuclease Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cas12 Nuclease Sales by Country (2021-2032)
- 5.5.3 Europe Cas12 Nuclease Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Cas12 Nuclease Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cas12 Nuclease Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cas12 Nuclease Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cas12 Nuclease Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cas12 Nuclease Market Facts & Figures by Country
- 5.7.1 South America Cas12 Nuclease Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cas12 Nuclease Sales by Country (2021-2032)
- 5.7.3 South America Cas12 Nuclease Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Cas12 Nuclease Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cas12 Nuclease Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cas12 Nuclease Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cas12 Nuclease Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Cas12 Nuclease Sales by Type (2021-2032)
- 6.1.1 Global Cas12 Nuclease Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Cas12 Nuclease Sales Market Share by Type (2021-2032)
- 6.2 Global Cas12 Nuclease Revenue by Type (2021-2032)
- 6.2.1 Global Cas12 Nuclease Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cas12 Nuclease Revenue Market Share by Type (2021-2032)
- 6.3 Global Cas12 Nuclease Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cas12 Nuclease Sales by Application (2021-2032)
- 7.1.1 Global Cas12 Nuclease Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Cas12 Nuclease Sales Market Share by Application (2021-2032)
- 7.2 Global Cas12 Nuclease Revenue by Application (2021-2032)
- 7.2.1 Global Cas12 Nuclease Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cas12 Nuclease Revenue Market Share by Application (2021-2032)
- 7.3 Global Cas12 Nuclease Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cas12 Nuclease Value Chain Analysis
- 8.1.1 Cas12 Nuclease Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cas12 Nuclease Production Mode & Process
- 8.2 Cas12 Nuclease Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cas12 Nuclease Distributors
- 8.2.3 Cas12 Nuclease Customers
9 Global Cas12 Nuclease Analyzing Market Dynamics
- 9.1 Cas12 Nuclease Industry Trends
- 9.2 Cas12 Nuclease Industry Drivers
- 9.3 Cas12 Nuclease Industry Opportunities and Challenges
- 9.4 Cas12 Nuclease Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst